Last reviewed 2026-04-23 · How we verify

HRS-7535 tablet

HRS-7535 tablet's mechanism of action is not publicly available.

At a glance

Mechanism of action

Due to limited information, the exact mechanism of HRS-7535 tablet is unknown.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes (PHASE2)
• A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects (PHASE1)
• Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity (PHASE2)
• Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i. (PHASE2)
• Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects (PHASE2)
• A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity (PHASE3)
• A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise (PHASE3)
• A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.